FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

GRANULES

319.5
+5.65 (1.8%)
Updated 10:38 22/06 IST

GRANULES Buy or Sell - FrontPage Forums

9 Users have submitted 9 trade ideas of Rs. 638,490.25 for GRANULES
Disclaimer
100% Bullish
0% Bearish

GRANULES Buy or Sell - Brokerage Reports

No. of reports in last year
5
No. of analysts
4
Average Consensus Forecast
418.4
Consensus Potential
23.69%
See GRANULES Share Price Targets >>

GRANULES Ratings

Long term GRANULES rating by FrontPage users
4/5 (3 Ratings)
Find answers to all your questions on live GRANULES message board: Is GRANULES buy or sell? Should I buy GRANULES shares? Why are GRANULES shares falling? Should I invest in GRANULES stock?

  1. Home
  2. GRANULES Forum

GRANULES Share Price Discussion

Like
Reply
Like
Reply
Like
Reply
Like
Reply
Like
Reply
Like
Reply
Like
Reply
Like
Reply
Like
Reply
Like
Reply
Like
Reply
Like
Reply

Sold #GRANULES options - GRANULES21JUN370CE at 0.50
Like
Reply
Like
Reply
Like
Reply
Like
Reply

Type
Sell
Instrument
GRANULES
Entry Price
₹312.55
Price@Trade
₹312.55
Target Price
₹302
Stop Price
₹317
Valid Till
Jun 18, 2021 3:20 AM
Margin
₹31,255 approx for 100 Qty
Status
Validity Over
Exit Price
₹310.45
Net P&L
+₹210 (+0.67%)

Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jun 18 8:50 AM

Update
Validity Over
Exit Price
₹310.45
Net P&L
+₹210 (+0.67%)
Like
Reply
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • GRANULES - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization2,905.51
    Enterprise Value3,776.07
    Price to Earnings18.9
    Price to Book Value2.04
    Return on Capital Employed0.11
    Return on Equity0.11
    Face Value1
    Dividend Yield0.01
  • GRANULES - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    12-May-21Motilal OswalBuy420
    11-May-21SharekhanBuy475
    21-Oct-20ICICIdirect.comBuy460
    12-Sep-20Motilal OswalBuy410
    20-Jul-20Geojit Financial ServicesBuy327
    GRANULES Brokerage Price Target
  • GRANULES Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jun 21308314.8303.1313.85
    Jun 18318320.3308.45310.8
    Jun 17321321.65316317.2
    Jun 16329.5329.7323323.7
    Jun 15330333.45327.55328.5
  • GRANULES Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹322.33
    30 Day Moving Average₹325.79
    50 Day Moving Average₹328.83
    100 Day Moving Average₹330.3
    200 Day Moving Average₹351.45
  • GRANULES - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue1,6471,349.480.22
    Operating Profit294295.8-0.01
    Profit Before Tax208206.80.01
    Net Income139142.83-0.03
  • GRANULES - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds1,4231,2780.11
    Total Liabilities1,4011,3400.05
    Total Assets2,8242,6180.08
  • GRANULES - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity24197.22-0.88
    Cash from Investing Activity-495-292.750.69
    Cash from Financing Activity52924.220.86
    Net Cash Flow58-71.34-1.81
  • GRANULES - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.050.08
    Return on Equity0.110.16
    Return on Capital Employed0.110.16
  • GRANULES - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.36
    3 Year CAGR Growth in Operating Profit0.4
    3 Year CAGR Growth in EBIDTA0.49
    3 Year CAGR Growth in Net Income0.46
    3 Yr CAGR Growth - Diluted EPS0.18
  • GRANULES - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.42
    5 Year CAGR Growth in Operating Profit2.72
    5 Year CAGR Growth in EBIDTA2.92
    5 Year CAGR Growth in Net Income3.61
    3 Yr CAGR Growth - Diluted EPS-0.63
  • GRANULES - Recent News

    keyboard_arrow_down
    NewsBot
    May 19 4:06 AM
    Present tense, future perfect for this pharma multibagger; grab it if you have the patience
    The Economic Times
    NewsBot
    May 16 6:26 AM
    Granules India earmarks capex of Rs 1,000 crore till FY24
    The Economic Times
    NewsBot
    May 12 3:51 AM
    Buy Granules India, target price Rs 420: Motilal Oswal
    The Economic Times
    NewsBot
    May 11 12:31 PM
    Granules India Q4 results: Net profit rises 38% to Rs 128 cr
    The Economic Times
    NewsBot
    May 6 3:06 AM
    Buy Granules India, target price Rs 375: IIFL
    The Economic Times
    NewsBot
    Apr 9 5:31 AM
    Buy Granules India, target price Rs 363: ICICI Direct
    The Economic Times
    NewsBot
    Feb 1 4:21 AM
    Granules arm gets American health regulator's nod for Potassium Chloride Oral Solution
    The Economic Times
    NewsBot
    Jan 29 5:21 AM
    Buy Granules India, target price Rs 460: Motilal Oswal
    The Economic Times
    NewsBot
    Jan 13 6:16 AM
    Granules gets American drug regulator's nod for diabetes management drug Metformin
    The Economic Times
    NewsBot
    Jan 11 4:51 AM
    Buy Granules India, target price Rs 480: Motilal Oswal
    The Economic Times
  • GRANULES - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Cadila Healthcare Ltd. NSE: CADILAHC ...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020